CARYSIL Intrinsic Value
CARYSIL intrinsic value. CARYSIL (CARYSIL) median intrinsic value is ₹1023.33 from 10 valuation models (range ₹283–₹2361), vs current price ₹944.55 — +8.3% upside (Trading Near Calculated Value), margin of safety 7.7%. Analyse CARYSIL shareholder distribution to track promoter, FII and institutional holdings.
CARYSIL Valuation Methods Summary — DCF, Graham Number & P/E
CARYSIL intrinsic value across 10 models vs current price ₹944.55 — upside/downside and value range per method. For current market price and key ratios, visit CARYSIL share price chart.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹478.56 | ₹382.85 - ₹574.27 | -49.3% | EPS: ₹39.88, Sector P/E: 12x |
| Book Value Method | asset | ₹1023.33 | ₹921.00 - ₹1125.66 | +8.3% | Book Value/Share: ₹1023.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1493.33 | ₹1344.00 - ₹1642.66 | +58.1% | Revenue/Share: ₹1866.67, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1889.10 | ₹1700.19 - ₹2078.01 | +100.0% | EBITDA: ₹224.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹2361.38 | ₹1889.10 - ₹2833.66 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹283.36 | ₹255.02 - ₹311.70 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹328.61 | ₹295.75 - ₹361.47 | -65.2% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1889.10 | ₹1700.19 - ₹2078.01 | +100.0% | ROE: 18.9%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹958.25 | ₹862.43 - ₹1054.08 | +1.5% | EPS: ₹39.88, BVPS: ₹1023.33 |
| Dividend Yield Method | dividend | ₹283.36 | ₹255.02 - ₹311.70 | -70.0% | DPS: ₹3.00, Target Yield: 3.5% |
CARYSIL Intrinsic Value vs Market Price — All Valuation Models
CARYSIL fair value range ₹283–₹2361 vs current market price ₹944.55 across 10 valuation models. Browse CARYSIL financial statements for revenue, profit, balance sheet and cash flow data.
CARYSIL Intrinsic Value Analysis — Undervalued or Overvalued?
CARYSIL median intrinsic value ₹1023.33, current price ₹944.55 — Trading Near Calculated Value by 8.3%, margin of safety 7.7%.
What is the intrinsic value of CARYSIL?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of CARYSIL (CARYSIL) is ₹1023.33 (median value). With the current market price of ₹944.55, this represents a +8.3% variance from our estimated fair value.
The valuation range spans from ₹283.36 to ₹2361.38, indicating ₹283.36 - ₹2361.38.
Is CARYSIL undervalued or overvalued?
Based on our multi-method analysis, CARYSIL (CARYSIL) appears to be trading near calculated value by approximately 8.3%.
CARYSIL Financial Health — Key Ratios vs Industry Benchmarks
CARYSIL financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 18.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 19.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.07x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
CARYSIL Cash Flow Quality — Operating & Free Cash Flow
CARYSIL operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹109 Cr | ₹65 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹60 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹53 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹71 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹52 Cr | ₹16 Cr | Positive Free Cash Flow | 7/10 |